Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M D Drici

Showing results (11-20 of 40) with videos related to

Pageof 4
Sort By:
Archives Des Maladies Du Coeur Et Des Vaisseaux|February 17, 2006
[The best of clinical cardiovascular pharmacology in 2005]R Ambrosi, M Andrejak, M D Drici, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux|July 1, 1990
[Evaluation of the placebo effect on blood pressure profile during exercise in patients with mild uncomplicated hypertension]M D Drici, M Roux, E Ferrari, et al.
Molecular Pharmacology|October 10, 1998
HERG and KvLQT1/IsK, the cardiac K+ channels involved in long QT syndromes, are targets for calcium channel blockersC Chouabe, M D Drici, G Romey, et al.
British Journal of Pharmacology|March 2, 1999
Effects of phrixotoxins on the Kv4 family of potassium channels and implications for the role of Ito1 in cardiac electrogenesisS Diochot, M D Drici, D Moinier, et al.
British Journal of Pharmacology|October 4, 2000
The bee venom peptide tertiapin underlines the role of I(KACh) in acetylcholine-induced atrioventricular blocksM D Drici, S Diochot, C Terrenoire, et al.
Presse Medicale (Paris, France : 1983)|September 16, 1989
[Is treatment with molar lactate in flecainide poisoning safe?]E Ferrari, J P Fournier, P Gibelin, et al.
International Journal of Clinical Pharmacology Research|January 1, 1992
Placebo effect in cardiovascular clinical pharmacologyP Iacono, M D Drici, C De Lunardo, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux|February 18, 2005
[The best of clinical pharmacology in 2004]P Ambrosi, M Andrejak, M D Drici, et al.
JAMA|December 8, 1998
Cardiac actions of erythromycin: influence of female sexM D Drici, B C Knollmann, W X Wang, et al.
British Journal of Clinical Pharmacology|February 1, 1995
Influence of the behaviour pattern on the nocebo response of healthy volunteersM D Drici, F Raybaud, C De Lunardo, et al.
Pageof 4

Showing results (11-20 of 40) with videos related to

Sort By:
Pageof 4
Archives Des Maladies Du Coeur Et Des Vaisseaux|February 17, 2006
[The best of clinical cardiovascular pharmacology in 2005]R Ambrosi, M Andrejak, M D Drici, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux|July 1, 1990
[Evaluation of the placebo effect on blood pressure profile during exercise in patients with mild uncomplicated hypertension]M D Drici, M Roux, E Ferrari, et al.
Molecular Pharmacology|October 10, 1998
HERG and KvLQT1/IsK, the cardiac K+ channels involved in long QT syndromes, are targets for calcium channel blockersC Chouabe, M D Drici, G Romey, et al.
British Journal of Pharmacology|March 2, 1999
Effects of phrixotoxins on the Kv4 family of potassium channels and implications for the role of Ito1 in cardiac electrogenesisS Diochot, M D Drici, D Moinier, et al.
British Journal of Pharmacology|October 4, 2000
The bee venom peptide tertiapin underlines the role of I(KACh) in acetylcholine-induced atrioventricular blocksM D Drici, S Diochot, C Terrenoire, et al.
Presse Medicale (Paris, France : 1983)|September 16, 1989
[Is treatment with molar lactate in flecainide poisoning safe?]E Ferrari, J P Fournier, P Gibelin, et al.
International Journal of Clinical Pharmacology Research|January 1, 1992
Placebo effect in cardiovascular clinical pharmacologyP Iacono, M D Drici, C De Lunardo, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux|February 18, 2005
[The best of clinical pharmacology in 2004]P Ambrosi, M Andrejak, M D Drici, et al.
JAMA|December 8, 1998
Cardiac actions of erythromycin: influence of female sexM D Drici, B C Knollmann, W X Wang, et al.
British Journal of Clinical Pharmacology|February 1, 1995
Influence of the behaviour pattern on the nocebo response of healthy volunteersM D Drici, F Raybaud, C De Lunardo, et al.
Pageof 4